Bullfrog AI Holdings, Inc. Warrants (BFRGW)

USD 0.54

(7.92%)

Market Cap (In USD)

-

Revenue (In USD)

65 Thousand

Net Income (In USD)

-5.35 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.53-0.65
PE
-
EPS
-
Beta Value
2.2623882
ISIN
US12021E1174
CUSIP
CIK
1829247
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Mr. Vininder Singh
Employee Count
-
Website
https://www.bullfrogai.com
Ipo Date
2023-01-20
Details
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.